The WACC of Japan Vietnam Medical Instrument JSC (JVC.VN) is 11.7%.
| Range | Selected | |
| Cost of equity | 10.70% - 13.80% | 12.25% |
| Tax rate | 2.00% - 3.30% | 2.65% |
| Cost of debt | 7.00% - 7.00% | 7.00% |
| WACC | 10.3% - 13.1% | 11.7% |
| Category | Low | High |
| Long-term bond rate | 3.3% | 3.8% |
| Equity market risk premium | 8.3% | 9.3% |
| Adjusted beta | 0.89 | 1.02 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 10.70% | 13.80% |
| Tax rate | 2.00% | 3.30% |
| Debt/Equity ratio | 0.1 | 0.1 |
| Cost of debt | 7.00% | 7.00% |
| After-tax WACC | 10.3% | 13.1% |
| Selected WACC | 11.7% | |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for JVC.VN:
cost_of_equity (12.25%) = risk_free_rate (3.55%) + equity_risk_premium (8.80%) * adjusted_beta (0.89) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.